Table 2.
mRNA and protein expression of balloon cells (BC) and giant cells (GC) of mTOR and cell growth markers.
| Category | Cell marker | BC | GC | Function | Notes and references |
|---|---|---|---|---|---|
| pAkt | ++ | + | TSC 1 and 2 suppressor | mRNA data suggest normal expression in GC but increased in BC (Rossini et al., 2017; Schick et al., 2007a) | |
| mTOR pathway Cell growth marker |
Hamartin | u | - | Tumor suppressor; mTOR suppressor | BC/GC (Jozwiak et al., 2004; Grajkowska et al., 2008) |
| Tuberin | u | - | |||
| pPDK | ++ | ++ | Signal transduction in mTOR | mRNA expression is also shown in BC/GC (Rossini et al., 2017; Schick et al., 2007a) | |
| p4EBP1 | + | + | Translation initiation factor | mRNA expression is also shown in BC/GC; More focal, more variable expression in BC (Yasin et al., 2010) | |
| pTuberin | ++ | ++ | Inactivated tuberin/TSC2 | Only shown in mRNA so far (Schick et al., 2007a) | |
| Actin Stress Fiber | ++ | ++ | Disrupts actin skeleton | Only shown in mRNA so far (Schick et al., 2007a) | |
| pS6 | ++ | ++ | Protein synthesis, cell proliferation, apoptosis, and metabolism | BC/GC (Rossini et al., 2017) | |
| p-p70(S6k) | ++ | ++ | Cell proliferation, growth, and cell cycle progression | Only shown in mRNA so far (Schick et al., 2007a) | |
| Cell growth pathways | MCM2 | + | + | G1 cell stage marker | unable to be activated with stem cell mitogens in BC/GC (Yasin et al., 2010) |
| IGF2 | ++ | + | Insulin growth factor | Only shown in mRNA so far; Normal expression in GC (Baybis et al., 2004) | |
| Ki67 | - | + | Cell proliferation marker and immature neuronal marker | BC (Munakata et al., 2013) GC (Crino et al., 1996; Crino et al., 1997) |
|
| Inflammation markers | LILRB2 | + | +++ | Modulates neurite growth, synaptic plasticity, and inflammatory responses | BC/GC (Yue et al., 2019) |
| TLR4 | ++ | ++ | Toll-like receptor involved in neurogenesis | BC/GC (Arena et al., 2019) | |
| IL-1β | ++ | ++ | Proinflammatory cytokine involved in neuronal development | BC/GC (Arena et al., 2019) | |
| IL-6/IL-6R | +++ | +++ | Proinflammatory cytokine involved in neuronal development | Colocalization with GFAP in BC, but not GC (Shu et al., 2010) | |
| IL-17/IL17R | + | + | Activates innate and adaptive immunity | 2x higher compared to cortex in BC/GC (He et al., 2013) | |
| TGF-β | u | u | Regulates response to cell injury, including modulating cell growth | Only shown in mRNA so far (Baybis et al., 2004) | |
| FPR2 | + | + | Inflammatory resolution in CNS; Negatively correlated with NF-kB | Weakly shown in GC/BC (Huang et al., 2022) |
-: “not expressed” u: “Under expressed”; +: Expressed (may be weakly expressed or normal expression); ++: “Overexpressed”; +++: “Strongly Expressed.”All studies examined human cortical samples. Unless otherwise noted, all studies are immunohistochemical studies of protein expression.